VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program

Toronto, Ontario–(Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company”), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today announced the launch of its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical™ brand.Beacon Medical™ 2:100 high-dose CBD oil…
Read more on “Newsfile”